Abstract:Highlights • Glioblastoma is an aggressive brain tumor with high rate of recurrence. • Implantable biomaterials are promising approaches against glioblastoma relapse. • Soy protein hydrogels embedding drug-loaded liposomes were pioneering fabricated. • Varying soy protein amount and liposome size, a controlled release is achieved. • The liposomes released from hydrogels are intact and active on glioblastoma cells. Glioblastoma (GB) is the most common and aggressive brain tumor. The treatment for newly diagnosed glioblastoma is surgical resection of the primary tumor mass, followed by radiotherapy and chemotherapy. However, recurrences frequently occur in proximity to the surgical resection area. In these cases, none of the current therapies is effective. Recently, implantable biomaterials seem to be a promising strategy against GB recurrence. Here, for the first time we combined the tailorable properties of soy-protein hydrogels with the versatility of drug-loaded liposomes to realize a hybrid biomaterial for controlled and sustained nanoparticles release. Hydrogel consisting of 18–20 % w/v soy-protein isolated were fabricated in absence of chemical cross-linkers. They were biodegradable (−10 % and −30 % of weight by hydrolytic and enzymatic degradation, respectively in 3 days), biocompatible (>95 % of cell viability after treatment), and capable of sustained release of intact doxorubicin-loaded liposomes (diffusion coefficient between 10 −18 and 10 −19 m 2 s −1 ). A proof-of-concept in a "donut-like" 3D-bioprinted model shows that liposomes released by hydrogels were able to diffuse in a model with a complex extracellular matrix-like network and a 3D structural organization, targeting glioblastoma cells. The combination of nanoparticles' encapsulation capabilities with the hydrogels' structural support and controlled release properties will provide a powerful tool with high clinical relevance that could be applicable for the treatment of other cancers, realizing patient-specific interventions. Graphical abstract Scheme 1- Graphical Illustration of the proposed strategy to counteract GB recurrence. After surgical resection of the newly diagnosed GB, SPI hydrogel embedding drug-loaded liposomes will be implanted for the controlled release of nanomedicines. Download : Download high-res image (274KB) Download : Download full-size image

Sustainable release of carmustine from biodegradable poly[((D,L))-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies

Poly(ethylene Glycol) Based Nanotubes for Tuneable Drug Delivery to Glioblastoma Multiforme

Long Acting Carmustine Loaded Natural Extracellular Matrix Hydrogel for Inhibition of Glioblastoma Recurrence after Tumor Resection

Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability

Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme

Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme

T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma.

Three weeks release BCNU loaded hydrophilic-PLGA microspheres for interstitial chemotherapy: Development and activity against human glioblastoma cells

Novel multi-drugs incorporating hybrid-structured nanofibers enhance alkylating agent activity in malignant gliomas

Silk Microneedle Patch Capable of On‐Demand Multidrug Delivery to the Brain for Glioblastoma Treatment

BCNU/PLGA Microspheres: a Promising Strategy for the Treatment of Gliomas in Mice.

A biodegradable nanocapsule for through-skull NIR-II fluorescence imaging/magnetic resonance imaging and selectively enhanced radio-chemotherapy for orthotopic glioma

Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles

Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma

An injectable in situ hydrogel platform for sustained drug release against glioblastoma

Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for Ph-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism

In vitro study of controlled biodegradable high molecular superfine fiber PLA release system for glioma

Electrospun Poly (L-Lactic Acid)/gelatine Membranes Loaded with Doxorubicin for Effective Suppression of Glioblastoma Cell Growth in Vitro and in Vivo.

Biopolymer immune implants co-loaded with TMZ, R848 and IOX1 for perioperative therapy of glioblastoma

Biodegradable SPI-based hydrogel for controlled release of nanomedicines: A potential approach against brain tumors recurrence

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors